NCT07031518

Brief Summary

To date, treatment options for knee osteoarthritis remain limited, and their clinical evaluation is complex due to the day-to-day fluctuations in symptoms. Hospital tests provide a point-in-time measurement that is influenced by various factors (fatigue, recent activity, weather, etc.), making reliable assessment difficult. The aim of the study is to assess the feasibility and acceptability of monitoring actual activity using the Syde® portable device in up to 30 subjects. Numerical variables derived from data collected by Syde® will be compared with conventional on-site clinical assessment criteria and with data from healthy participants, in order to identify a reliable and robust metric, thereby improving treatment evaluation and personalised patient management. MAIN OBJECTIVES

  • Evaluate the use of the device
  • Identify numerical variables and determine the optimal time window for evaluation Patients will have two visits: one at inclusion and a second two months later. They will wear Syde® magneto-inertial sensors, one on each ankle, for the month following the initial visit, then a Syde® sensor on the ankle and another on the wrist on the side of the non-dominant hand for the following month. The total duration of the recording period is two months.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
43

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 14, 2025

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

May 15, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

June 22, 2025

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 28, 2025

Completed
2 days until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2025

Completed
Last Updated

March 24, 2026

Status Verified

March 1, 2026

Enrollment Period

7 months

First QC Date

May 15, 2025

Last Update Submit

March 23, 2026

Conditions

Keywords

osteoarthritis of the kneedigital outcome

Outcome Measures

Primary Outcomes (4)

  • Total Recording Time Over 2 Months

    Total number of hours recorded by the Syde® wearable device over a 2-month period.

    2 months

  • Median Daily Recording Time

    Median number of hours recorded per day by the Syde® device over the 2-month period.

    2 months

  • Days to Reach 180 Recording Hours

    Number of days required to reach 180 hours of recording, considered the optimal threshold for analysis.

    2 months

  • Intra-Class Correlation of Syde® Outcomes

    Intra-Class Correlation (ICC) of each Syde® outcome calculated over slices of x hours (x = 10 to 90) of data per patient to assess reliability.

    Entire recording period over 2 months

Secondary Outcomes (7)

  • Correlation Between Syde® Variables and WOMAC 3.1 Scores

    Baseline and 2 months

  • Correlation Between Syde® Variables and Timed Tests

    Baseline and 2 months

  • Correlation Between Syde® Variables and Kellgren-Lawrence Grade

    Baseline

  • Discriminative Power of Syde® Variables

    Entire recording period over 2 months

  • Qualitative Interview on Mobility and Usability

    Baseline and Month 2

  • +2 more secondary outcomes

Study Arms (2)

Patient with osteoarthritis of the knee

ACTIVE COMPARATOR

Patients will have two visits: one at inclusion and a second two months later. They will wear Syde® magneto-inertial sensors, one on each ankle, for the month following the initial visit, then a Syde® sensor on the ankle and another on the wrist on the side of the non-dominant hand for the following month. The total duration of the recording period is two months.

Device: SydeDiagnostic Test: The Self-Paced 40-meter Walk Test (SPWT)Diagnostic Test: 30-second chair stand test (30s-CST)Diagnostic Test: The Timed up and go test (TUG)Diagnostic Test: Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC 3.1)Diagnostic Test: Patient global impression of severity (PGI-S)Other: Pain Level DiaryOther: Qualitative Interview

Healthy Subjects

ACTIVE COMPARATOR

Healthy subjects with similar age and BMI to patients with osteoarthritisof the knee

Device: SydeDiagnostic Test: The Self-Paced 40-meter Walk Test (SPWT)Diagnostic Test: 30-second chair stand test (30s-CST)Diagnostic Test: The Timed up and go test (TUG)

Interventions

SydeDEVICE

Actimyo/Syde is an innovative device intended to be used in a home-based environment. It is composed of two watch-like sensors, each containing a magneto-inertial sensors that record the linear acceleration, the angular velocity, the magnetic field of the movement in all directions.The two watches can be worn as wristwatch or placed near the ankle.

Healthy SubjectsPatient with osteoarthritis of the knee

Assesses walking speed over a fixed distance by having participants walk as quickly and safely as possible, but without running, along a 40-meter course.

Healthy SubjectsPatient with osteoarthritis of the knee

It is a simple assessment of lower body strength and endurance. Participants are instructed to stand up and sit down from a chair as many times as possible in 30 seconds.

Healthy SubjectsPatient with osteoarthritis of the knee

During this standardized test, the subject is observed and timed while he/she rises from a chair, walks 3 meters, performs a 180° turn, walk back toward the chair and sits down.

Healthy SubjectsPatient with osteoarthritis of the knee

The WOMAC is a widely used self-administered health status measure for evaluating pain, stiffness, and function in patients with osteoarthritis of the hip or knee. The WOMAC measures three separate dimensions: pain (5 questions), stiffness (2 questions) and function (17 questions).

Patient with osteoarthritis of the knee

The PGI-S is a patient-reported measure that evaluates the perceived severity of a condition based on a standardized scale, ranging from "none" to "very severe".

Patient with osteoarthritis of the knee

Patients will record their specific OAK average pain level during the day using the VAS scale of 0-10 points for one week at the beginning of each month of recording.

Patient with osteoarthritis of the knee

This interview is designed to better understand the patient's perspective on the impact of osteoarthritis of the knee on their motor function and to inform the selection of digital tools in upcoming clinical studies.

Patient with osteoarthritis of the knee

Eligibility Criteria

Age40 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with bi- or unilateral Knee Osteoarthritis as confirmed by a qualified rheumatologist/orthopaedist or rehabilitation doctor and having had at least one X-ray or MRI for diagnosis confirmation with Kellgren-Lawrence grade minimum 1
  • WOMAC 3.1 total score at screening indicating mild, moderate, or severe symptoms in the past 48 hours
  • BMI below 35.0 kg/m2

You may not qualify if:

  • Patients with significant cognitive disorders, limiting the understanding of the exercises to be performed or the presence of apparent communication difficulties hindering the correct collection of data.
  • Unable to walk independently (10 meters without any type of external help)
  • History of any joint replacement surgery.
  • Currently undergoing or had corticosteroid injections within the past 3 weeks.
  • Underwent knee surgery in the past 6 months.
  • Expecting joint replacement surgery or arthroscopy within 3 months.
  • Pregnant women or women planning to become pregnant during the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre de référence des maladies neuromusculaire (CRMN Liège), Hopital de la Citadelle

Liège, 4000, Belgium

Location

MeSH Terms

Conditions

Osteoarthritis, Knee

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Study Officials

  • Laurent Servais, MD, PhD

    Centre Hospitalier Universitaire de Liege

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator, Neurologist

Study Record Dates

First Submitted

May 15, 2025

First Posted

June 22, 2025

Study Start

May 14, 2025

Primary Completion

November 28, 2025

Study Completion

November 30, 2025

Last Updated

March 24, 2026

Record last verified: 2026-03

Locations